Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

PURPOSE: In the absence of head-to-head trial data, network meta-analysis (NMA) was used to compare trastuzumab emtansine (T-DM1) with other approved treatments for previously treated patients with unresectable or metastatic HER2-positive breast cancer (BC). METHODS: Systematic reviews were conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103014/
https://www.ncbi.nlm.nih.gov/pubmed/32100144
http://dx.doi.org/10.1007/s10549-020-05577-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103014/
https://www.ncbi.nlm.nih.gov/pubmed/32100144
http://dx.doi.org/10.1007/s10549-020-05577-7

Ejemplares similares